Kelonia Therapeutics
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $50M
Investors
- 3
About Kelonia Therapeutics
, aka Kelonia, is a biotech firm offering therapeutic platform that offers clinical solutions to patients dealing with diseases such as malignants and others. In April 2026, Eli Lilly and Company Limited agreed to acquire Kelonia Therapeutics, Inc.75 billion upon achieving milestones. The firm offers a lentiviral vector gene delivery platform to carry genetic payload solely to the appropriate tissue for treating a broad range of diseases such as tumors, cancers, and others. The acquisition enables Eli Lilly to add an in vivo CAR-T gene delivery platform that engineers cancer-fighting cells directly in patients, reducing reliance on complex lab-based CAR-T manufacturing and expanding its oncology pipeline, including treatments for multiple myeloma.
Who invested in Kelonia Therapeutics
3 investors across 2 rounds
See all investors in Kelonia Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kelonia Therapeutics
Who invested in Kelonia Therapeutics?
Kelonia Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kelonia Therapeutics raised?
Kelonia Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Kelonia Therapeutics last raise money?
Kelonia Therapeutics's most recent round on record is a Series A, in Apr 2022.
What does Kelonia Therapeutics do?
, aka Kelonia, is a biotech firm offering therapeutic platform that offers clinical solutions to patients dealing with diseases such as malignants and others.
Where is Kelonia Therapeutics headquartered?
Kelonia Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Kelonia Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kelonia Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kelonia Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.